A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancer. Cho BC, Johnson M, Bar J, Schaefer E, et al. Lung Cancer 2025;202:108492.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cho BC, Johnson M, Bar J, Schaefer E, et al. A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancer. Lung Cancer 2025;202:108492.
PMID: 40086026